Blood test may predict who benefits most from weight loss surgery
NCT ID NCT07241741
Summary
This study looked at whether measuring a specific protein (PTX3) in the blood before surgery could help predict how well patients would respond to weight loss surgery. Researchers followed 23 patients undergoing gastric bypass surgery, checking their weight, insulin resistance, and inflammation markers at 3 and 6 months after the procedure. The goal was to see if the pre-surgery PTX3 level could forecast who would experience the best improvements in metabolism and inflammation reduction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.